Request Deal Involvement
F-Prime Capital, Forbion, and Norwest led a $157m Series B round in Engrail Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
or
Principals
target
ENGRAIL THERAPEUTICS
bidder
F-PRIME CAPITAL
bidder
FORBION CAPITAL PARTNERS
bidder
NORWEST VENTURE PARTNERS
bidder
RIVERVEST VENTURE PARTNERS
bidder
RED TREE VENTURE CAPITAL
bidder
ABRDN INC
bidder
YSIOS CAPITAL
bidder
LONGWOOD FUND
bidder
EIGHT ROADS VENTURES
bidder
PIVOTAL LIFE SCIENCES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite